2021. ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression. Biomolecules and Biomedicine. 21, 3 (Jun. 2021), 294–304. DOI:https://doi.org/10.17305/bjbms.2020.4701.